The Use of Cyclosporine in Pediatric Recipients of Renal Transplants

  • B. D. Kahan
  • C. T. Van Buren
  • S. B. Conley
  • M. I. Lorber
  • S. M. Flechner
Part of the Developments in Nephrology book series (DINE, volume 17)


The superior results of cyclosporine (CsA) immunosuppression in combination with prednisone (Pred), which was initiated at the University of Texas Medical School at Houston for adult patients in August, 1980, compared to the previous azathioprine-Pred combination, led to application of this regimen to pediatric recipients one year later (1). On the one hand, there were the concerns of carcinogenicity, and particularly in a pediatric population that CsA-induced nephrotoxicity would produce chronic renal dysfunction sufficient to prevent post-transplant growth and development. On the other hand, the possible benefit of improved graft survival and reduced numbers of rejection episodes decreasing the cumulative steroid dose proffered better rehabilitation. The present communication describes our four year experience with the CsA-Pred regimen in 34 children aged 1.5 to 16 years.


Graft Survival Allograft Rejection Rejection Episode Pediatric Recipient Texas Medical School 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kahan, B.D., Van Buren, C., Flechner, S., Payne, W.D., Boileau, M., and Kerman, R.: Cyclosporine immunosuppression mitigates immunologie risk factors in renal allotransplantation. Transplant. Proc. 15(4): 2469–2478, 1983.Google Scholar
  2. 2.
    Kahan, B.D.: Overview: individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic para-meters. Transplantation 40: 457, 1985.PubMedCrossRefGoogle Scholar
  3. 3.
    Kahan, B.D.: Clinical summation: an algorithm for the management of patients with cyclosporine-induced renal dys-function. Transplant. Proc. 17: 303, 1985.PubMedGoogle Scholar
  4. 4.
    Hamill, P.V., Drizd, T., Johnson, C., et al.: Am. J. Clin. Nutr. 32: 607, 1979.PubMedGoogle Scholar
  5. 5.
    Conley, S.B., Brewer, E., Flechner, S., Van Buren, C.T., and Kahan, B.D.: Renal transplantation using cyclosporine in pediatric patients 3 to 17 years old. Transplant. Proc. 15(4): 2528, 1983.Google Scholar
  6. 6.
    Flechner, S.M., Conley, S.B., Rose, G., Van Buren, C., Kerman, R., Lorber, M., and Kahan, B.D.: Cyclosporine and prednisone immunosuppression in pediatric recipients of renal allografts. Actua Sandoz, 1986: in press.Google Scholar
  7. 7.
    Fine, R.N.: J. Pediatr. 100: 754, 1982.PubMedCrossRefGoogle Scholar
  8. 8.
    Kahan, B.D., Van Buren, C.T., Flechner, S., Jarowenko, M., Yasumura, T., Rogers, A.J., Yoshimura, N., LeGrue, S., Drath, D.B., and Kerman, R.H.: Clinical and experimental studies using cyclosporine in renal transplantation. Surgery 97: 125, 1985.PubMedGoogle Scholar
  9. 9.
    Pennisi, A.J., Costin, G., Phillips, L.: Am. J. Dis. Child. 133: 950, 1979.PubMedGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1987

Authors and Affiliations

  • B. D. Kahan
  • C. T. Van Buren
  • S. B. Conley
  • M. I. Lorber
  • S. M. Flechner

There are no affiliations available

Personalised recommendations